Advertisement for orthosearch.org.uk
Results 141 - 160 of 347
Results per page:
Bone & Joint 360
Vol. 8, Issue 6 | Pages 12 - 15
1 Dec 2019


Bone & Joint 360
Vol. 8, Issue 5 | Pages 35 - 37
1 Oct 2019


Bone & Joint 360
Vol. 8, Issue 2 | Pages 36 - 38
1 Apr 2019


Bone & Joint 360
Vol. 8, Issue 4 | Pages 37 - 39
1 Aug 2019


Bone & Joint 360
Vol. 8, Issue 4 | Pages 19 - 21
1 Aug 2019


Bone & Joint Research
Vol. 8, Issue 3 | Pages 146 - 155
1 Mar 2019
Langton DJ Natu S Harrington CF Bowsher JG Nargol AVF

Objectives

We investigated the reliability of the cobalt-chromium (CoCr) synovial joint fluid ratio (JFR) in identifying the presence of a severe aseptic lymphocyte-dominated vasculitis-associated lesion (ALVAL) response and/or suboptimal taper performance (SOTP) following metal-on-metal (MoM) hip arthroplasty. We then examined the possibility that the CoCr JFR may influence the serum partitioning of Co and Cr.

Methods

For part A, we included all revision surgeries carried out at our unit with the relevant data, including volumetric wear analysis, joint fluid (JF) Co and Cr concentrations, and ALVAL grade (n = 315). Receiver operating characteristic curves were constructed to assess the reliability of the CoCr JFR in identifying severe ALVAL and/or SOTP. For part B, we included only patients with unilateral prostheses who had given matched serum and whole blood samples for Co and Cr analysis (n = 155). Multiple regression was used to examine the influence of JF concentrations on the serum partitioning of Co and Cr in the blood.


The Bone & Joint Journal
Vol. 101-B, Issue 1_Supple_A | Pages 32 - 40
1 Jan 2019
Hellman MD Ford MC Barrack RL

Aims

Surface replacement arthroplasty (SRA), compared with traditional total hip arthroplasty (THA), is more expensive and carries unique concern related to metal ions production and hypersensitivity. Additionally, SRA is a more demanding procedure with a decreased margin for error compared with THA. To justify its use, SRA must demonstrate comparable component survival and some clinical advantages. We therefore performed a systematic literature review to investigate the differences in complication rates, patient-reported outcomes, stress shielding, and hip biomechanics between SRA and THA.

Materials and Methods

A systematic review of the literature was completed using MEDLINE and EMBASE search engines. Inclusion criteria were level I to level III articles that reported clinical outcomes following primary SRA compared with THA. An initial search yielded 2503 potential articles for inclusion. Exclusion criteria included review articles, level IV or level V evidence, less than one year’s follow-up, and previously reported data. In total, 27 articles with 4182 patients were available to analyze.


Bone & Joint 360
Vol. 8, Issue 3 | Pages 19 - 21
1 Jun 2019


Bone & Joint 360
Vol. 7, Issue 5 | Pages 30 - 33
1 Oct 2018


The Bone & Joint Journal
Vol. 101-B, Issue 5 | Pages 582 - 588
1 May 2019
Sidhu MS Cooper G Jenkins N Jeys L Parry M Stevenson JD

Aims

The aims of this study were to report the efficacy of revision surgery for patients with co-infective bacterial and fungal prosthetic joint infections (PJIs) presenting to a single institution, and to identify prognostic factors that would guide management.

Patients and Methods

A total of 1189 patients with a PJI were managed in our bone infection service between 2006 and 2015; 22 (1.85%) with co-infective bacterial and fungal PJI were included in the study. There were nine women and 13 men, with a mean age at the time of diagnosis of 64.5 years (47 to 83). Their mean BMI was 30.9 kg/m2 (24 to 42). We retrospectively reviewed the outcomes of these PJIs, after eight total hip arthroplasties and 14 total knee arthroplasties. The mean clinical follow-up was 4.1 years (1.4 to 8.8).


The Bone & Joint Journal
Vol. 101-B, Issue 5 | Pages 522 - 528
1 May 2019
Medellin MR Fujiwara T Clark R Stevenson JD Parry M Jeys L

Aims

The aim of this study was to evaluate the prosthesis characteristics and associated conditions that may modify the survival of total femoral endoprosthetic replacements (TFEPR).

Patients and Methods

In all, 81 patients treated with TFEPR from 1976 to 2017 were retrospectively evaluated and failures were categorized according to the Henderson classification. There were 38 female patients (47%) and 43 male patients (53%) with a mean age at diagnosis of 43 years (12 to 86). The mean follow-up time was 10.3 years (0 to 31.7). A survival analysis was performed followed by univariate and multivariate Cox regression to identify independent implant survival factors.


Bone & Joint 360
Vol. 7, Issue 4 | Pages 31 - 33
1 Aug 2018


Bone & Joint 360
Vol. 6, Issue 4 | Pages 31 - 34
1 Aug 2017


Bone & Joint 360
Vol. 8, Issue 1 | Pages 34 - 36
1 Feb 2019


Bone & Joint 360
Vol. 8, Issue 1 | Pages 37 - 39
1 Feb 2019


Bone & Joint 360
Vol. 7, Issue 6 | Pages 45 - 45
1 Dec 2018


Bone & Joint 360
Vol. 7, Issue 6 | Pages 43 - 44
1 Dec 2018
Foy MA


Bone & Joint 360
Vol. 7, Issue 6 | Pages 33 - 35
1 Dec 2018


Bone & Joint 360
Vol. 7, Issue 5 | Pages 45 - 45
1 Oct 2018


The Bone & Joint Journal
Vol. 100-B, Issue 12 | Pages 1640 - 1646
1 Dec 2018
Medellin MR Fujiwara T Clark R Jeys LM

Aims

The aim of this study was to describe, analyze, and compare the survival, functional outcome, and complications of minimally invasive (MI) and non-invasive (NI) lengthening total femoral prostheses.

Patients and Methods

A total of 24 lengthening total femoral prostheses, 11 MI and 13 NI, were implanted between 1991 and 2016. The characteristics, complications, and functional results were recorded. There were ten female patients and ten male patients. Their mean age at the time of surgery was 11 years (2 to 41). The mean follow-up was 13.2 years (seven months to 29.25 years). A survival analysis was performed, and the failures were classified according to the Modified Henderson System.